Citation Impact
Citing Papers
Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
2011
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
2007 StandoutScience
A hexahistidine-Zn 2+ -dye label reveals STIM1 surface exposure
2007 StandoutNobel
Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
2014 StandoutNobel
NOTCH Signaling Is Required for Formation and Self-Renewal of Tumor-Initiating Cells and for Repression of Secretory Cell Differentiation in Colon Cancer
2010 StandoutNobel
Hyperplasia and Carcinomas in Pten-Deficient Mice and Reduced PTEN Protein in Human Bladder Cancer Patients
2006 StandoutNobel
Evidence that Resistance to Nilotinib May Be Due to BCR-ABL, Pgp, or Src Kinase Overexpression
2008
Ferroptosis regulation by the NGLY1/NFE2L1 pathway
2022 StandoutNobel
The Serine Protease TMPRSS6 Is Required to Sense Iron Deficiency
2008 StandoutScienceNobel
Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
2017
Hallmarks of Cancer: The Next Generation
2011 Standout
Chemokine Networks and Breast Cancer Metastasis
2007
EGFR Antagonists in Cancer Treatment
2008 Standout
Biology of angiogenesis in tumors of the gastrointestinal tract
2003
Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview
1992
Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer
2011
Involvement of Members of the Cadherin Superfamily in Cancer
2009
Inflammation and metabolic disorders
2006 StandoutNature
Role for the p53 homologue p73 in E2F-1-induced apoptosis
2000 StandoutNatureNobel
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Induction of neuropilin-1 and vascular endothelial growth factor by epidermal growth factor in human gastric cancer cells
2003
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
2014 StandoutNatureNobel
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Pharmacology of imatinib (STI571)
2002
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
2015 StandoutNature
Cell-Cell Contacts Prevent Anoikis in Primary Human Colonic Epithelial Cells
2006
Tenets of PTEN Tumor Suppression
2008
Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias
2006 Standout
Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations?
2008
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
2005 StandoutNobel
PTEN: One Gene, Many Syndromes
2003
Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
2009
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
2009
ErbBs in lung cancer
2008
Role of Hypoxia-Inducible Factor 1 in Gastric Cancer Cell Growth, Angiogenesis, and Vessel Maturation
2004 StandoutNobel
Regulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Angiogenesis by an Insulin-Like Growth Factor-I Receptor Autocrine Loop in Human Pancreatic Cancer
2003 StandoutNobel
Ubiquitin-dependent regulation of COPII coat size and function
2012 StandoutNatureNobel
Nickel carcinogenesis
2003 Standout
The semaphorins: versatile regulators of tumour progression and tumour angiogenesis
2008
Transforming Growth Factor-α Prevents Detachment-induced Inhibition of c-Src Kinase Activity, Bcl-XLDown-regulation, and Apoptosis of Intestinal Epithelial Cells
2001
Oncogenic Mutations Counteract Intrinsic Disorder in the EGFR Kinase and Promote Receptor Dimerization
2012 StandoutNobel
c-mos proto-oncogene product is partly degraded after release from meiotic arrest and persists during interphase in mouse zygotes
1991
Overexpression of E2F‐1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo
1998
AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties
2009
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
2003
Blocking Neuropilin-1 Function Has an Additive Effect with Anti-VEGF to Inhibit Tumor Growth
2007
Nickel essentiality, toxicity, and carcinogenicity
2002
Portrait of PTEN: Messages from mutant mice
2008 StandoutNobel
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
Differential Effects of Gefitinib and Cetuximab on Non–small-cell Lung Cancers Bearing Epidermal Growth Factor Receptor Mutations
2005
Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells
2007
HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion
2008
Head and Neck Cancer
1993 Standout
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
2011 StandoutNobel
The PtdIns(3,4)P2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death
2010 StandoutNatureNobel
Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array
2006
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
2010
PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival
2005
Hypoxia-inducible Factor-1 Deficiency Results in Dysregulated Erythropoiesis Signaling and Iron Homeostasis in Mouse Development
2006 StandoutNobel
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
MUC1 and the MUCs: A Family of Human Mucins with Impact in Cancer Biology
2004
Disruption of c-mos causes parthenogenetic development of unfertilized mouse eggs
1994 StandoutNatureNobel
Cancer-related inflammation
2008 StandoutNature
Targeting endothelial and tumor cells with semaphorins
2007
Modes of resistance to anti-angiogenic therapy
2008 Standout
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
2009 StandoutNature
Independent inactivation of MPF and cytostatic factor (Mos) upon fertilization of Xenopus eggs
1991 StandoutNatureNobel
The role of pericytes in blood-vessel formation and maintenance
2005
Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck
1989
Pericytes and vessel maturation during tumor angiogenesis and metastasis
2010
Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer.
2002
β-Arrestin2 mediates the initiation and progression of myeloid leukemia
2012 StandoutNobel
Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I.
1998
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
The von Hippel–Lindau tumor suppressor gene product represses oncogenic β-catenin signaling in renal carcinoma cells
2006
Characterization of human laryngeal primary and metastatic squamous cell carcinoma cell lines UM-SCC-17A and UM-SCC-17B.
1989
Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists
1999 StandoutNobel
The role of neuropilins in cancer
2006
p37mos-associated serine/threonine protein kinase activity correlates with the cellular transformation function of v-mos
1986
Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1.
2003 StandoutNobel
Chromosome 3p deletions in head and neck carcinomas: Statistical ascertainment of allelic loss
1992
Effects of the v-mos oncogene on Xenopus development: meiotic induction in oocytes and mitotic arrest in cleaving embryos.
1990
Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression
2014 StandoutNobel
The bone marrow constitutes a reservoir of pericyte progenitors
2006
Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.
2001
Cell Cycle Control and Cancer
1994 StandoutScienceNobel
Serine kinase activity associated with moloney murine sarcoma virus-124-encoded p37mos
1985
Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph + leukemia in mice
2006
β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7
2009 StandoutNobel
Mos is required for MAP kinase activation and is involved in microtubule organization during meiotic maturation in the mouse
1996 StandoutNobel
Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia.
2001
Breast cancer during pregnancy.
2001
What brings pericytes to tumor vessels?
2003
Kinase requirements in human cells: III. Altered kinase requirements inVHL−/− cancer cells detected in a pilot synthetic lethal screen
2008 StandoutNobel
Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
1999
Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
2003
Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts.
2000
Targeting Signal Transduction Pathways in Colorectal Cancer—More Than Skin Deep
2005
Chemically tunable mucin chimeras assembled on living cells
2015 StandoutNobel
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
Cancer Genome Landscapes
2013 StandoutScience
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Hypoxia-Associated Factor, a Novel E3-Ubiquitin Ligase, Binds and Ubiquitinates Hypoxia-Inducible Factor 1α, Leading to Its Oxygen-Independent Degradation
2008
Use and Abuse of RNAi to Study Mammalian Gene Function
2012 StandoutScienceNobel
Cell cycle arrest and c-mos
1992 StandoutNatureNobel
Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines.
1989
Combined inhibition of VEGF‐ and PDGF‐signaling enforces tumor vessel regression by interfering with pericyte‐mediated endothelial cell survival mechanisms
2003
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells
2005
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Works of Gary E. Gallick being referenced
Sustained Src Inhibition Results in Signal Transducer and Activator of Transcription 3 (STAT3) Activation and Cancer Cell Survival via Altered Janus-Activated Kinase–STAT3 Binding
2009
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
2009
Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents
2012
CXCL-12/Stromal Cell–Derived Factor-1α Transactivates HER2-neu in Breast Cancer Cells by a Novel Pathway Involving Src Kinase Activation
2005
Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells
2005
Src activation of Stat3 is an independent requirement from NF-κB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells
2006
HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas
2005 StandoutNobel
Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer.
1993
Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells
2007
Efficacy and Antivascular Effects of EphA2 Reduction With an Agonistic Antibody in Ovarian Cancer
2006
Autocrine growth stimulation by transforming growth factor-α in human non-small cell lung cancer
1992
Impact of Insulin-Like Growth Factor Receptor-I Function on Angiogenesis, Growth, and Metastasis of Colon Cancer
2002
Benzodiazepine Compounds as Inhibitors of the Src Protein Tyrosine Kinase: Screening of a Combinatorial Library of 1,4-Benzodiazepines
1999
Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases
2006
Src, chemoresistance and epithelial to mesenchymal transition: are they related?
2007
Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice
2009
Src activation regulates anoikis in human colon tumor cell lines
2002
Insulinlike Growth Factor-I???Mediated Migration and Invasion of Human Colon Carcinoma Cells Requires Activation of c-Met and Urokinase Plasminogen Activator Receptor
2005
Regulation of Cdc25C by ERK-MAP Kinases during the G2/M Transition
2007
Down-regulation of Vascular Endothelial Growth Factor in a Human Colon Carcinoma Cell Line Transfected with an Antisense Expression Vector Specific for c-src
1998
AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts
2007
Vascular endothelial growth factor is upregulated by interleukin-1β in human vascular smooth muscle cells via the P38 mitogen-activated protein kinase pathway
2001
Down‐modulation of epidermal growth factor receptor accompanies TNF‐induced differentiation of the DiFi human adenocarcinoma cell line toward a goblet‐like phenotype
1993
Nuclear PTEN-Mediated Growth Suppression Is Independent of Akt Down-Regulation
2005
Neuropilin-1 Suppresses Tumorigenic Properties in a Human Pancreatic Adenocarcinoma Cell Line Lacking Neuropilin-1 Coreceptors
2005
Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated β-catenin
2003
Recognition of mos-related Proteins with an Antiserum to a Peptide of the v-mos Gene Product
1985
Treatment for Advanced Tumors: Src Reclaims Center Stage
2006
Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells.
2002
Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck.
1988
The gag-mos hybrid protein of ts110 moloney murine sarcoma virus: variation of gene expression with temperature
1984
Extracellular signal-regulated kinase activation is required for up-regulation of vascular endothelial growth factor by serum starvation in human colon carcinoma cells.
1999
Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma.
1988
Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by activity of src kinase
1997
Molecular Mechanisms of Resistance to Therapies Targeting the Epidermal Growth Factor Receptor
2005
Nickel-induced heritable alterations in retroviral transforming gene expression
1987
Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
2003
Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway
2009
P85gag-mos Encoded by ts110 Moloney Murine Sarcoma Virus: Rapid at the Restrictive Temperature
1983
BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571
2002
Transforming growth factor-alpha production and autoinduction in a colorectal carcinoma cell line (DiFi) with an amplified epidermal growth factor receptor gene.
1993
Expression of epidermal growth factor receptor and associated glycoprotein on cultured human brain tumor cells
1986
Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival
2001
In vivo intracellular signaling as a marker of antiangiogenic activity.
2001
Cell Cycle–Dependent Nuclear Export of Phosphatase and Tensin Homologue Tumor Suppressor Is Regulated by the Phosphoinositide-3-Kinase Signaling Cascade
2007
Activation of Src kinase in primary colorectal carcinoma
2002
Expression of p21ras in fresh primary and metastatic human colorectal tumors.
1985